ON-01

AXP000138.1 · Oncolytic virus

Platform
HSV-1 (cytosine deaminase-armed)
Originator
Beijing Neurosurgical Institute
Sponsor
Beijing Neurosurgical Institute

Names

NameTypeSource
ON-01 ambiguouspreferred name, codecurator, ctgov

Virus

Role
Oncolytic
Family
Orthoherpesviridae
Virus
herpes simplex virus 1 (NCBI Taxonomy 10298)
Replication
conditionally replicating
Modifications
engineered HSV-1 carrying a cytosine deaminase gene, used with flucytosine
Transgenes
cytosine deaminase (CD)
Route
intracerebral
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06562621Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant GliomaCompletedPhase 1/22018-08-012022-08-0138Glioblastoma Multiforme; Gliomas, Malignant

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 41527280ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study.Neuro-oncology2026name in title: ON-01

Notes

Engineered oncolytic HSV-1 carrying a cytosine deaminase (CD) gene, given with flucytosine (5-FC, listed as 'ONF') in recurrent malignant glioma: phase 1/2 NCT06562621 at Beijing Tiantan Hospital, shown as completed. Backbone deletions are not described in the registration.

How to cite

ON-01 (AXP000138.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000138.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.